Pharmacists in Amherst, Ohio


13 Pharmacists found in Amherst
female pharmacist

Angela Mcguire, R.PH.


Pharmacist
8000 Oak Point Rd, T-2351, Amherst, OH 44001
440-985-7101     440-985-7109

female pharmacist

Diane E Meyer, RPH


Pharmacist
8000 Oak Point Rd, T-2351, Amherst, OH 44001
440-985-7101     440-985-7109

male pharmacist

James White, R.PH.


Pharmacist
541 Fieldstone Dr, Amherst, OH 44001
440-984-3481    



male pharmacist

James M Moran, PHARMD


Pharmacist
2201 Kresge Dr, Amherst, OH 44001
440-282-7651     440-282-7663

female pharmacist

Jennifer Carroll, PHARMD


Pharmacist
100 S Leavitt Rd, Amherst, OH 44001
440-988-5832    

male pharmacist

Keith Higgins


Pharmacist
357 Copper Crk, Amherst, OH 44001
440-308-6721    

female pharmacist

Lauren Rachel Miller, PHARMD


Pharmacist
45243 Quail Hollow Ct, Amherst, OH 44001
440-396-0754    

male pharmacist

Mark L Biczykowski, RPH


Pharmacist
100 S Leavitt Rd, Amherst, OH 44001
440-988-5832     440-984-3779

male pharmacist

Mr. Michael Kalivoda, RPH


Pharmacist
100 S Leavitt Rd, Amherst, OH 44001
440-988-5832    

female pharmacist

Samantha Dawn Golden, PHARMD


Pharmacist
100 S Leavitt Rd, Amherst, OH 44001
440-988-5832    

male pharmacist

Shane Burnsworth


Pharmacist
917 N Lake St, Amherst, OH 44001
440-798-6050     216-201-8203

male pharmacist

Mr. Stephan Arthur Miller, R.PH.


Pharmacist
254 Cleveland Ave, Amherst Hospital Pharmacy, Amherst, OH 44001
440-988-6230     440-988-6012

male pharmacist

Mr. Steve Medve


Pharmacist
2201 Kresge Dr, Amherst, OH 44001
440-282-7651     440-282-7663


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.